Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorena Dima

Showing results (11-20 of 68) with videos related to

Pageof 7
Sort By:
Drugs|September 15, 2020
Pharmacological Management of Glucose Dysregulation in Patients Treated with Second-Generation AntipsychoticsSimona Cernea, Lorena Dima, Christoph U Correll, et al.
American Journal of Therapeutics|February 6, 2018
Clozapine for Treatment-Refractory Behavioral Disturbance in DementiaAndreea Teodorescu, Lorena Dima, Petru Ifteni, et al.
American Journal of Therapeutics|September 1, 2022
Comprehensive Targeted Treatment for Neuropathic and Nociceptive Pain in Palliative Care PatientsMaria-Mirabela Mihailescu-Marin, Daniela Viorica Mosoiu, Lorena Dima
American Journal of Therapeutics|January 8, 2026
Omalizumab: First Approved Anti-IgE Therapy for Multiple Food AllergiesDinesh Yogaratnam, S Mimi Mukherjee, Katie Getchell, et al.
Expert Review of Clinical Pharmacology|January 19, 2018
The pharmacological management of metabolic syndromeJulie Rask Larsen, Lorena Dima, Christoph U Correll, et al.
American Journal of Therapeutics|October 7, 2025
Xanomeline/Trospium (Cobenfy): A Novel Approach for the Treatment of Schizophrenia in AdultsAna Aliana Miron, Petru Iulian Ifteni, Timothy Nguyen, et al.
American Journal of Therapeutics|November 3, 2023
Nivolumab/Relatlimab-rmbw: A Novel Dual Combination Therapy to Treat Adult and Pediatric Patients With Unresectable or Metastatic MelanomaBaily Thomas, Madison Burns, Helen Pervanas, et al.
Expert Opinion on Drug Metabolism & Toxicology|June 6, 2022
Drug-drug interactions involving antipsychotics and antihypertensivesCatalin Adrian Buzea, Lorena Dima, Christoph U Correll, et al.
Expert Opinion on Drug Metabolism & Toxicology|November 12, 2022
Drug-drug interactions involving combinations of antipsychotic agents with antidiabetic, lipid-lowering, and weight loss drugsCatalin Adrian Buzea, Peter Manu, Lorena Dima, et al.
American Journal of Therapeutics|May 1, 2024
Edaravone Oral Suspension: A Neuroprotective Agent to Treat Amyotrophic Lateral SclerosisPriya Singh, Paul Belliveau, Jennifer Towle, et al.
Pageof 7

Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
Drugs|September 15, 2020
Pharmacological Management of Glucose Dysregulation in Patients Treated with Second-Generation AntipsychoticsSimona Cernea, Lorena Dima, Christoph U Correll, et al.
American Journal of Therapeutics|February 6, 2018
Clozapine for Treatment-Refractory Behavioral Disturbance in DementiaAndreea Teodorescu, Lorena Dima, Petru Ifteni, et al.
American Journal of Therapeutics|September 1, 2022
Comprehensive Targeted Treatment for Neuropathic and Nociceptive Pain in Palliative Care PatientsMaria-Mirabela Mihailescu-Marin, Daniela Viorica Mosoiu, Lorena Dima
American Journal of Therapeutics|January 8, 2026
Omalizumab: First Approved Anti-IgE Therapy for Multiple Food AllergiesDinesh Yogaratnam, S Mimi Mukherjee, Katie Getchell, et al.
Expert Review of Clinical Pharmacology|January 19, 2018
The pharmacological management of metabolic syndromeJulie Rask Larsen, Lorena Dima, Christoph U Correll, et al.
American Journal of Therapeutics|October 7, 2025
Xanomeline/Trospium (Cobenfy): A Novel Approach for the Treatment of Schizophrenia in AdultsAna Aliana Miron, Petru Iulian Ifteni, Timothy Nguyen, et al.
American Journal of Therapeutics|November 3, 2023
Nivolumab/Relatlimab-rmbw: A Novel Dual Combination Therapy to Treat Adult and Pediatric Patients With Unresectable or Metastatic MelanomaBaily Thomas, Madison Burns, Helen Pervanas, et al.
Expert Opinion on Drug Metabolism & Toxicology|June 6, 2022
Drug-drug interactions involving antipsychotics and antihypertensivesCatalin Adrian Buzea, Lorena Dima, Christoph U Correll, et al.
Expert Opinion on Drug Metabolism & Toxicology|November 12, 2022
Drug-drug interactions involving combinations of antipsychotic agents with antidiabetic, lipid-lowering, and weight loss drugsCatalin Adrian Buzea, Peter Manu, Lorena Dima, et al.
American Journal of Therapeutics|May 1, 2024
Edaravone Oral Suspension: A Neuroprotective Agent to Treat Amyotrophic Lateral SclerosisPriya Singh, Paul Belliveau, Jennifer Towle, et al.
Pageof 7